What To Expect

Cutting-Edge Science: Discover the latest advances in liver cancer, MASH, and metabolism

National Experts: Learn from leading researchers and clinicians shaping the future of the field.

Next-Generation Research: Explore emerging discoveries through student presentations and a poster session.

Community Voices: Connect science with the experiences and perspectives of communities affected by liver disease and cancer.

Collaboration & Connection: Build relationships across research, clinical care, institutions, and disciplines.

Innovation in Action: Explore promising therapeutic strategies and how discoveries can translate into patient impact.

A Special Two-Day Symposium on Liver Cancer, HCC, and MASH

This year, the Gordon Ginder Innovations in Cancer Symposium is going bigger than ever. Join us for a special two-day, nationally advertised symposium presented in partnership with the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health.

This year’s program will spotlight the rapidly evolving science at the intersection of liver disease, cancer, and metabolism, with a focus on hepatocellular carcinoma (HCC) and metabolic dysfunction-associated steatohepatitis (MASH).

Bringing together nationally recognized experts in cancer biology, hepatology, metabolism, and translational research, the symposium will explore the latest discoveries and emerging approaches to understanding, preventing, and treating HCC and MASH. Attendees will have the opportunity to hear from leading investigators, engage in scientific discussion, and connect with colleagues working across disciplines. The program will also showcase the next generation of researchers through student presentations and a poster session, as well as community conversations that will bring additional perspectives to the discussion and connect scientific discovery with the experiences and needs of those affected by liver disease and cancer.

The symposium also supports the scientific goals of ELEVATE (ExpLoiting thErapeutic VulnerAbilities in hepaTocEllular carcinoma), a P01 grant led by Massey investigator Dr. Devanand Sarkar. Sessions will highlight promising therapeutic vulnerabilities and new strategies for translating discoveries in liver cancer biology into better approaches for patients.

Come be part of this exciting scientific exchange as Massey and the VCU Stravitz-Sanyal Institute bring together a national community of experts, students, trainees, and community members to share discoveries, spark new collaborations, and advance the future of liver cancer and metabolic liver disease research.

EVENT LOCATION

Richmond is the perfect blend of urban edginess and southern charm! It's the capital city of the Commonwealth of Virginia, and it's a place where you can find antebellum architecture and over 100 murals.

We are excited to host the Conference in the heart of the city, where you'll find the Richmond Marriott (500 E Broad St, Richmond, VA 23219), which offers a prime location that puts you just steps from the city's historic past.

Room reservation information: COMING SOON!

HISTORY

This symposium honors Gordon D. Ginder, MD, who has dedicated a lifetime to Massey's cancer research and patient care.

Dr. Ginder held the Lipman Chair in Oncology and served as director of VCU Massey Comprehensive Cancer Center from 1997 to 2019. As one of the longest-standing National Cancer Institute-designated Cancer Center directors, Dr. Ginder left a lasting legacy that has impacted countless lives within and beyond our community. Under his leadership, Massey took on and maintained a trajectory of carefully planned steady growth, substantially built its scientific base and output fueled by a fourfold increase in extramural, philanthropic and state funding for life-saving cancer research.

He successfully led five highly competitive renewals for Massey’s NCI designation. During his tenure, critical state-of-the-art spaces for cancer research, training and care were expanded across the university and health system, including the addition of Goodwin Research Laboratory, the first building at VCU dedicated solely to cancer research. He also oversaw the development of a strong research program in cancer prevention and control and strengthened multidisciplinary cancer care.

“Ginder’s visionary and dedicated leadership of Massey leaves a lasting legacy that has impacted countless lives within and beyond our community.”

-Marsha Rappley, MD, Former CEO of VCU Health System